Lance Armstrong's Endurance Protocol: What It Would Cost a Non-Celebrity

What Lance Armstrong Actually Admitted To

Armstrong's confession came in two parts. The January 17, 2013 interview with Oprah Winfrey provided the public admission. The U.S. Anti-Doping Agency's (USADA) Reasoned Decision, published in October 2012, provided the clinical detail. Together, they outlined a multi-substance endurance protocol spanning at least six of Armstrong's seven Tour de France victories.

The Oprah Interview: Confirmed Substances

Armstrong confirmed using EPO, testosterone, cortisone, human growth hormone, and blood transfusions. He described the protocol as part of the "program" run by the U.S. Postal Service cycling team. His exact words: "I viewed it as level, not as gaining an advantage." He denied using these substances after his 2009 comeback, a claim USADA contested.

The USADA Reasoned Decision

USADA's 1,000+ page document drew testimony from 26 individuals, including 15 riders 1. The decision described a systematic doping program involving microdoses of EPO timed to avoid detection windows, testosterone patches applied at night and removed before morning tests, and periodic autologous blood transfusions during Grand Tours. Dr. Michele Ferrari, the team physician, was identified as the architect of the dosing schedules.

What Was Not Confirmed

Armstrong never publicly specified exact doses, frequencies, or cycling schedules for each substance. The dosing estimates used in cost projections below are based on what USADA testimony described and what published sports medicine literature reports as typical endurance-doping protocols 2.

Erythropoietin (EPO): The Core of the Protocol

EPO was the centerpiece. Recombinant human erythropoietin increases red blood cell production, raising oxygen-carrying capacity and directly improving endurance performance. A 2007 meta-analysis in the British Journal of Sports Medicine found that EPO administration improved time-trial performance by 3% to 7% in trained cyclists 3.

How EPO Works for Endurance

EPO stimulates erythropoiesis in bone marrow. In clinical medicine, it treats anemia from chronic kidney disease, chemotherapy, and certain inflammatory conditions. The FDA approved epoetin alfa (Epogen, Procrit) in 1989 for these indications 4. When used for doping, athletes target hematocrit levels of 49% to 50%, just below the 50% threshold the UCI historically used as a health check cutoff.

What EPO Costs Today

Epoetin alfa carries a wholesale acquisition cost of roughly $250 to $500 per 10,000-unit vial. Clinical anemia dosing typically starts at 50 to 100 units/kg three times weekly. For a 75 kg athlete using performance-oriented doses (reported in doping literature as 20 to 50 units/kg every other day during loading phases), the monthly cost without insurance ranges from $300 to $800 5.

Biosimilar options have reduced costs. Retacrit (epoetin alfa-epbx), approved in 2018, runs approximately 15% to 30% cheaper than branded Procrit. With insurance covering a legitimate anemia diagnosis, out-of-pocket costs may drop to $50 to $150 per month. Without a qualifying diagnosis, no insurer will cover it.

The Cardiovascular Risk Premium

The FDA placed a black box warning on all erythropoiesis-stimulating agents (ESAs) in 2007, citing increased risks of death, myocardial infarction, stroke, and venous thromboembolism when targeting hemoglobin levels above 11 g/dL 4. Athletes pushing hematocrit to 49% to 50% operate well above this threshold. Several professional cyclists died of cardiac events during the EPO era of the 1990s, and while direct causation was never confirmed in most cases, the temporal association prompted the UCI to institute hematocrit testing.

Testosterone: The Recovery Accelerator

Armstrong used testosterone to accelerate recovery between stages. The USADA testimony described transdermal testosterone patches applied at night. One witness, Tyler Hamilton, testified that riders would set alarms to remove patches before early-morning anti-doping controls.

Legitimate TRT vs. Performance Dosing

FDA-approved testosterone replacement therapy (TRT) targets serum testosterone levels of 300 to 1,000 ng/dL for men with diagnosed hypogonadism 6. The Endocrine Society's 2018 clinical practice guideline recommends testosterone cypionate 75 to 100 mg intramuscularly weekly or 150 to 200 mg every two weeks as standard replacement dosing.

Performance-oriented users often exceed these ranges. Published case series describe doses of 200 to 600 mg weekly among strength athletes, though endurance athletes like cyclists typically use lower doses to avoid weight gain and maintain power-to-weight ratios 7.

Monthly Cost Breakdown

Testosterone cypionate is among the most affordable prescription medications in hormone therapy:

• Generic testosterone cypionate (200 mg/mL, 10 mL vial): $30 to $90 at retail pharmacies with a GoodRx-type discount
• Brand-name Depo-Testosterone: $80 to $200 per vial
• Testosterone patches (Androderm): $300 to $600 per month, the format Armstrong reportedly used
• Compounded testosterone cream: $40 to $120 per month through compounding pharmacies
• Telehealth TRT clinics: $150 to $300 per month including medication, labs, and consultations

For a non-celebrity seeking legitimate TRT with monitoring labs (total testosterone, free testosterone, hematocrit, PSA, lipid panel), expect $200 to $400 per month all-in at a men's health clinic 6.

Human Growth Hormone: The Expensive Addition

Armstrong confirmed HGH use. Recombinant human growth hormone (somatropin) was approved by the FDA for adult growth hormone deficiency and carries the highest price tag of any substance in the admitted protocol.

Prescription HGH Pricing

Somatropin products (Genotropin, Norditropin, Humatrope, Omnitrope) range widely in cost:

• Omnitrope (biosimilar): $500 to $900 per month at anti-aging clinic doses (1 to 2 IU daily)
• Genotropin: $1,000 to $2,500 per month depending on dose
• Norditropin: $800 to $2,000 per month
• Black-market or gray-market HGH: Prices quoted online range from $300 to $1,000 per month, but purity and dosing accuracy are unverifiable

The Endocrine Society recommends against prescribing growth hormone for anti-aging or athletic performance purposes 8. Insurance covers somatropin only for documented growth hormone deficiency confirmed by stimulation testing.

Performance Evidence Is Weak

A 2017 systematic review in the Annals of Internal Medicine examined 44 studies of GH administration in athletes and found modest increases in lean body mass but no consistent improvement in strength, power, or endurance performance 9. The evidence for GH as an endurance enhancer is substantially weaker than for EPO or blood transfusions. Its inclusion in doping protocols may reflect a recovery and body-composition rationale rather than direct performance enhancement.

Cortisone: The Inflammation Manager

Armstrong tested positive for corticosteroids during the 1999 Tour de France but produced a backdated prescription for a saddle-sore cream containing triamcinolone. USADA later concluded this was part of a broader pattern of cortisone use for performance purposes.

What Cortisone Actually Costs

Cortisone is cheap. It is one of the least expensive components of any performance protocol:

• Oral prednisone (generic): $4 to $15 per month
• Cortisone injection at an outpatient clinic: $50 to $350 per session, typically administered every 3 to 6 months
• Triamcinolone acetonide cream: $10 to $40 for a tube

The anti-inflammatory benefits for a stage-race cyclist are straightforward: reduced muscle inflammation, joint pain suppression, and the ability to recover between consecutive days of racing. The World Anti-Doping Agency (WADA) prohibits systemic glucocorticoids in competition but permits topical and local injections with a therapeutic use exemption 10.

Blood Transfusions: The Undetectable Boost

Autologous blood transfusions (reinfusing an athlete's own stored blood) were central to the USADA case. Unlike EPO, autologous transfusions leave no synthetic marker in standard drug tests. This made them the preferred method during Grand Tours when testing frequency increased.

How It Works

An athlete withdraws 1 to 2 units of blood (450 to 900 mL) weeks before competition, stores it under refrigeration, then reinfuses it during the event to boost red blood cell count. The effect is similar to EPO: higher hematocrit, greater oxygen delivery, improved endurance output. A 2006 study in Medicine & Science in Sports & Exercise demonstrated a 5% to 7% improvement in VO2max following autologous transfusion of 2 units 11.

Cost for a Non-Celebrity

This is the most logistically complex and expensive component. It requires:

• A cooperative medical professional willing to perform the extraction and storage
• Proper blood storage equipment (a medical-grade refrigerator maintaining 1 to 6°C)
• Sterile reinfusion under clinical conditions
• Estimated cost per procedure: $1,500 to $5,000 including medical oversight, storage, and supplies

Blood doping is prohibited under WADA rules and carries risks including bacterial contamination, transfusion reactions, and iron depletion 12. No legitimate medical indication exists for autologous blood transfusion in a healthy athlete outside of pre-surgical banking.

Total Monthly Cost Estimate for a Non-Celebrity

Assembling the full protocol Armstrong described, here is what a non-celebrity would pay at 2026 prices through legitimate (where applicable) and cash-pay channels:

| Substance | Monthly Cost Range | Notes | |---|---|---| | EPO (epoetin alfa) | $300, $800 | Cash price, no insurance for performance use | | Testosterone (cypionate or patches) | $50, $400 | Wide range by formulation | | HGH (somatropin) | $500, $2,500 | Biosimilar to branded | | Cortisone (oral or injectable) | $10, $100 | Cheapest component | | Blood transfusions | $375, $1,250/mo amortized | 3 to 4 procedures per year | | Lab monitoring | $100, $300 | CBC, hematocrit, hormones, liver panel | | Total | $1,335, $5,350 | |

The lower bound assumes generic medications, biosimilar EPO, minimal HGH dosing, and infrequent blood procedures. The upper bound reflects branded products, higher doses, and more frequent transfusions during a competition season.

How Armstrong's Access Differed

Armstrong had access to Dr. Michele Ferrari, a sports physician who reportedly charged elite cyclists $10,000 to $15,000 per year for consultation and protocol design. The U.S. Postal Service team budget covered much of the cost, as did prize money and sponsorship income estimated at over $100 million during Armstrong's career peak. A non-celebrity would bear every dollar directly.

Insurance Will Not Cover This

No health insurance plan in the United States covers EPO, testosterone, or HGH for performance enhancement. Insurance covers these substances only for specific FDA-approved indications: EPO for chronic kidney disease anemia, testosterone for documented hypogonadism, HGH for confirmed growth hormone deficiency. A clinician prescribing these for athletic purposes without a qualifying diagnosis risks medical board sanctions and DEA scrutiny 13.

The Legal and Medical Reality in 2026

Every substance Armstrong admitted to using is available by prescription in the United States for legitimate medical conditions. EPO, testosterone, HGH, and cortisone are all FDA-approved drugs. The issue is indication, not availability.

What Is Legal

A man with diagnosed hypogonadism (total testosterone consistently below 300 ng/dL with symptoms) can receive testosterone cypionate for $30 to $90 per month with a valid prescription 6. A patient with chronic kidney disease and hemoglobin below 10 g/dL can receive EPO under nephrology supervision. These are standard medical treatments.

What Is Not

Using EPO to push hematocrit from a normal 42% to 49% in a healthy person is off-label, unsupported by evidence of net benefit, and carries documented thrombotic risk. Prescribing HGH for athletic purposes violates federal law under the 1990 Anabolic Steroids Control Act as amended 13. Blood transfusions for performance enhancement are prohibited under WADA and carry infection and hemolytic risks.

Monitoring Costs Add Up

Even setting aside the substances themselves, the lab monitoring required to use these drugs with any degree of safety is expensive. A responsible protocol would require quarterly blood work including complete blood count, comprehensive metabolic panel, lipid panel, PSA (for testosterone users), IGF-1 (for HGH users), and iron studies (for EPO users). Quest Diagnostics cash pricing puts this at $150 to $300 per panel, or $600 to $1,200 per year 14.

As of May 2026, EPO (epoetin alfa biosimilar) carries a GoodRx cash price of approximately $280 to $450 per 10,000-unit vial at major U.S. Retail pharmacies, while testosterone cypionate 200 mg/mL (10 mL) remains available for under $100 at most chains.